Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F2048
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-16 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 05-15 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 28M 24.39M 22.49M 21.15M 39.57M 2.64B 39.85M 268M 104M 1.3B 105M 103M 4.51B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 30.87M 26.9M 24.8M 23.32M 43.63M 2.91B 43.94M 295M 115M 1.43B 116M 113M 4.97B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Richard Blumberg
BRD | Director/Board Member | 69 | 10/11/2016 |
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.63% | -2.32% | +18.35% | -13.53% | 173B | ||
| +1.14% | -1.48% | -20.16% | +23.51% | 144B | ||
| -0.33% | -2.00% | -8.88% | -26.73% | 125B | ||
| +0.76% | -3.99% | -55.32% | -16.62% | 67.32B | ||
| +0.78% | +1.87% | +18.09% | -4.98% | 50.3B | ||
| -0.63% | +0.09% | -24.40% | -34.79% | 44.09B | ||
| +2.20% | -1.92% | +9.99% | +4.90% | 35.89B | ||
| -0.44% | -1.20% | +4.74% | +32.04% | 34.9B | ||
| +0.72% | -4.53% | -14.33% | -21.69% | 28.02B | ||
| Average | +0.54% | -2.12% | -7.99% | -6.43% | 78.07B | |
| Weighted average by Cap. | +0.54% | -2.00% | -6.57% | -6.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.1K 5.62K 5.29K 9.89K 660K 9.96K 66.89K 25.98K 325K 26.27K 25.71K 1.13M | 767K 668K 616K 579K 1.08M 72.29M 1.09M 7.33M 2.85M 35.62M 2.88M 2.82M 123M |
| Net income | -2.42M -2.11M -1.94M -1.83M -3.42M -228M -3.44M -23.1M -8.97M -112M -9.07M -8.88M -389M | -3.2M -2.78M -2.57M -2.41M -4.52M -301M -4.55M -30.54M -11.86M -148M -12M -11.74M -514M |
| Net Debt | 1.77M 1.54M 1.42M 1.34M 2.5M 167M 2.52M 16.92M 6.57M 82.25M 6.65M 6.51M 285M | 2.88M 2.51M 2.31M 2.17M 4.06M 271M 4.09M 27.48M 10.67M 134M 10.8M 10.56M 463M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















